SEI Investments’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

SEI Investments’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3,415	Closed	-$20K	–	2750
2022 Q2	$20K	Sell	3,415 -5,013	-59%	-$28.3K	﹤0.01%	2630
2022 Q1	$60K	Sell	8,428 -9,712	-54%	-$95.2K	﹤0.01%	2542
2021 Q4	$239K	Buy	18,140 +2,786	+18%	+$46.1K	﹤0.01%	2415
2021 Q3	$353K	Sell	15,354 -4,201	-21%	-$125K	﹤0.01%	2246
2021 Q2	$858K	Buy	19,555 +8,166	+72%	+$455K	﹤0.01%	1878
2021 Q1	$827K	Buy	11,389 +7,104	+166%	+$505K	﹤0.01%	1832
2020 Q4	$185K	Buy	4,285 +710	+20%	+$31.8K	﹤0.01%	2368
2020 Q3	$147K	Sell	3,575 -251	-7%	-$13K	﹤0.01%	2294
2020 Q2	$230K	Sell	3,826 -145	-4%	-$13.3K	﹤0.01%	2187
2020 Q1	$299K	Buy	+3,971	New	+$457K	﹤0.01%	1940

Other funds holding ORTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

SEI Investments's ORTX Position: Q3 2022 in Review

SEI Investments sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q3 2022, closing a stake of 3,415 shares — an estimated $20K sold.

SEI Investments first reported a position in ORTX in Q1 2020 and held it in 10 quarters. The position peaked at $858K in Q2 2021. 47 funds tracked by Wall St. Rank hold ORTX as of Q3 2022.

SEI Investments reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q3 2022 after selling out during the quarter.
SEI Investments sold 3,415 Orchard Therapeutics plc American Depositary Shares shares in Q3 2022, an estimated $20K.
SEI Investments first reported a position in Orchard Therapeutics plc American Depositary Shares in Q1 2020 and held it in 10 quarters.
SEI Investments's Orchard Therapeutics plc American Depositary Shares position peaked at $858K in Q2 2021.
47 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q3 2022.

Based on SEI Investments's 13F filing for Q3 2022, filed 14 Nov 2022.